Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht & AMELAG
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 29 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 2.414 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 0, wobei auf jede offiziell registrierte Infektion etwa 284 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 2.813 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 36 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 18.08.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
The C117D oxidation mimic reveals the monomeric structure of SARS-CoV-2 main protease. 01.09.2026
Single-Particle Tracking and Positional Phenotyping Reveals Variant-Specific Early Checkpoints in SARS-CoV-2 Cell Entry 17.08.2026
Case 7:Design of a Point-of-Care Diagnostic Device for SARS-CoV-2 Infections 17.08.2026
SARS-CoV-2 Vaccines Beyond the Pandemic Era, volume II 17.08.2026
Immunological Evaluation of mRNA‐LNP Vaccines Targeting Conserved S2 and NSP3 Domains of SARS‐CoV‐2 17.08.2026
SADS-CoV N protein antagonizes JAK-STAT signaling pathway by targeting STAT1 for degradation 17.08.2026
Electrostatic-Tuneable THz Metasurface Sensor for Simultaneous Detection of SARS-CoV-2 and Cervical Cancer Biomarkers 17.08.2026
Energy-efficient microwave-synthesized bimetallic ZIF-derived CoV layered double hydroxide nanosheets for flexible asymmetric supercapacitors 17.08.2026
Temporal, Demographic, and Geographic Patterns of Long COVID Incidence in Relation to SARS-CoV-2 Variant Emergence:Insights from the Texas All-Payer Claims Database (TX-APCD). 16.08.2026
The Salivary Immune Response Distinguishes SARS-CoV-2 Vaccination From Infection:A Two-Year Longitudinal Study of Antibody, Inflammatory and Proteomic Parameters 16.08.2026
Temporal, Demographic, and Geographic Patterns of Long COVID Incidence in Relation to SARS-CoV-2 Variant Emergence:Insights from the Texas All-Payer Claims Database (TX-APCD) 16.08.2026
MERS-CoV in the Middle East and Africa:from surveillance gaps in humans and dromedary camels to One Health frameworks for spillover, prevention, research and response preparedness 16.08.2026
Lung epithelial endothelin-1 drives iron dysregulation and skeletal injury after SARS-CoV-2 infection 16.08.2026
Discovery of Novel Druggable Binding Pockets on SARS-CoV-2 PLpro via Fragment Screening and Insights for Structure-Based Inhibitor Design 16.08.2026
Association between post-vaccination adverse events and subsequent COVID-19 booster uptake in the Netherlands. 15.08.2026
Exploring the potential benefits of allergen immunotherapy beyond respiratory allergy. 15.08.2026
Comment on “Association of Body Mass Index With SARS ‐ CoV ‐2 Infection in Inflammatory Arthritis Patients Receiving Biologic Therapy:Singapore National Biologics Register Findings” 15.08.2026
Measuring and removing near-duplicate contamination in alignment-free SARS-CoV-2 lineage classification benchmarks 15.08.2026
Association between physical activity before SARS-CoV-2 infection and functional disability 24 months after COVID-19:findings from the SulCOVID-19 longitudinal study 15.08.2026
High-Throughput On-Chip Screening Enables Rapid Adaptation of DNA Aptamers to SARS-CoV-2 Evolution 15.08.2026
A Retrospective Cohort Study:Neonatal survey of pregnant women infected with SARS-CoV-2 during pregnancy 15.08.2026
Correction to:Clonal interference and changing selective pressures shape the escape of SARS-CoV-2 from hundreds of antibodies. 14.08.2026
Safety and antiviral activity of inhaled siRNA SNS812 for treatment of mild-to-moderate COVID-19:a phase 2 randomized trial. 14.08.2026
Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants. 14.08.2026
Personality variability during development predicts alcohol use before and during the COVID-19 pandemic. 14.08.2026
Bidirectional changes in recorded pediatric asthma diagnoses with respiratory virus activity:A nationwide interrupted time-series analysis in Japan. 14.08.2026
Validation of the Postpartum Sleep Quality Scale and assessment of postpartum sleep quality in Vietnam during the COVID-19 pandemic. 14.08.2026
REenergizeME:intermittent hypoxia-hyperoxia treatment for myalgic encephalomyelitis/chronic fatigue syndrome-protocol for a randomised, placebo-controlled trial. 14.08.2026
Discovery of Novel Druggable Binding Pockets on SARS-CoV-2 PLpro via Fragment Screening and Insights for Structure-Based Inhibitor Design. 14.08.2026
Selective decay of interferon mRNAs controls antiviral immunity and innate memory. 14.08.2026
The association between resource availability and knowledge, attitudes, and practice about protective ventilation among ICU directors - A nationwide cross-sectional survey. 14.08.2026
Photonic-crystal hydraulic manometry quantifies epithelial basal compression for rapid, label-free functional screening. 14.08.2026
Concentration of hospital utilization in the capital area among elderly inpatients from non-capital regions in South Korea:Before and during the COVID-19 pandemic. 14.08.2026
High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination. 14.08.2026
Evaluating genetic diversity differences within a likelihood framework. 14.08.2026
Lung epithelial endothelin-1 drives iron dysregulation and skeletal injury after SARS-CoV-2 infection. 14.08.2026
A network-driven antiviral discovery pipeline for emerging RNA viruses:a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA). 14.08.2026
Integrating Chaos Game Representation with Convolutional Neural Networks for Accurate Classification of SARS-CoV-2 Variants 14.08.2026
High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination 14.08.2026
Point-of-Care SARS-CoV-2 Antigen Testing as a Triage Marker for Subsequent Severe COVID-19 in Symptomatic Outpatients:A Multicentre Cohort Study 14.08.2026
Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS‐CoV‐2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir 14.08.2026
Inhibiting the interaction between the mitochondrial receptor Tom70 and SARS CoV 2 Orf9b with small molecules 14.08.2026
Factors associated with SARS-CoV-2 seropositivity among undiagnosed adults 14.08.2026
Correction to:Clonal interference and changing selective pressures shape the escape of SARS-CoV-2 from hundreds of antibodies 14.08.2026
N1-methylpseudouridine enhances immunogenicity of RNA/lipid nanoparticle vaccines targeting SARS-CoV-2 spike and the model antigen ovalbumin 14.08.2026
Comprehensive overview of Postural Tachycardia Syndrome (POTS) in patients with SARS-COV-2 virus, prevalence, causes and treatment 14.08.2026
Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants 14.08.2026
Noncovalent SARS-CoV-2 main protease inhibitors targeting the catalytic dyad and primed substrate binding subsites 14.08.2026
Evaluating Phylogenetic and Ancestral Recombination Graph Approaches for Analyzing RNA Virus Recombination:A Case Study of SARS-CoV-2 in Vietnam 14.08.2026
Vaccine imprinting drives increased SARS-CoV-2 variant infection in children 13.08.2026
A HEK293T-derived explainable CatBoost signature for estimating HCoV-OC43 viral burden from host transcriptomes. 10.08.2026
Recovery trajectories and predictors of symptom resolution in post-COVID-19 condition:a population-based cohort study. 08.08.2026
State Eviction Moratoria and Foster Care Entries. 07.08.2026
Targeting host lipogenesis with a diarylamide inhibitor disrupts SARS-CoV-2 replication. 06.08.2026
SARS-CoV-2-induced IgG repertoires shape T cell responses, microRNA regulation, and autoreactivity according to disease severity. 03.08.2026
Cadherin 1 negatively regulates SARS-CoV-2 infection in the olfactory epithelium. 03.08.2026
Advances on Sensors and Diagnostics of SARS-CoV-2 Biomarkers. 01.08.2026
Exploration of Nirmatrelvir Derivatives as Optimized SARS-CoV-2 Antivirals. 01.08.2026
SARS-CoV-2 Neutralization Breadth Is Shaped by Variant Exposure and Immune History. 01.08.2026
Utilization of Saliva for Anti-SARS-CoV-2 Antibody Detection in the General Population. 01.08.2026
Freeze-Drying as a Novel Concentrating Method for Wastewater Detection of SARS-CoV-2. 01.08.2026
Cobalt(III)-Schiff Base Coordination to Nsp1, a SARS-CoV-2 Protein. 01.08.2026
Acceleration of type 1 diabetes onset during the COVID-19 pandemic. 31.07.2026
DNA oligonucleotides block viral entry of SARS-CoV-2 Omicron variants. 30.07.2026
DABPU-DE targeting host adipose triglyceride lipase provides broad-spectrum anti-coronavirus effects in vitro. 29.07.2026
Deciphering the temporal and spatial mutation dynamics of the SARS-CoV-2 spike glycoprotein. 29.07.2026
Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers. 28.07.2026
SARS-CoV-2 resistance pathways to EDP-235. 27.07.2026
Genetic diversity and evolution of SARS-CoV-2 in the republic of Niger over 3 years. 27.07.2026
Oleuropein aglycone aldehyde as a SARS-CoV-2 main protease inhibitor. 23.07.2026
Complement augments antibody neutralization of SARS-CoV-2 variants. 22.07.2026
SARS-CoV-2 Vaccination and Immune Thrombocytopenia in Children:A Multicenter Study. 21.07.2026
Amantadine-induced reorganization of model SARS-CoV-2 lipid envelopes. 21.07.2026
Empirical substitution models of SARS-CoV-2 protein evolution for phylogenetic inference 21.07.2026
Long-term SARS-CoV-2 Persistence in Syrian Hamsters 20.07.2026
Preservation of Humoral Immunity and Response to Vaccination in Patients With IgAN Treated With Felzartamab. 09.07.2026
Fitness flux in SARS-CoV-2 and influenza H3N2 06.07.2026
Structural Features of a Tiny Viral Protein, ORF7b of SARS-CoV-2. 04.07.2026
SARS-CoV-2 and Cancer Biology:Exploring the Mechanistic Links. 01.07.2026
Children's Birthday Gatherings and SARS-CoV-2 Infection in Grandparents. 01.07.2026
[Genomic Characterization of SARS-CoV-2 by Next-Generation Sequencing Analysis]. 01.07.2026
Economic evaluation of wastewater surveillance in Ontario, Canada, using COVID-19 as a case study. 30.06.2026
Age-dependent disease tolerance to SARS-CoV-2 infection 30.06.2026
SARS-CoV-2 and diabetes:a post-pandemic reappraisal. 27.06.2026
Genomic Surveillance of SARS-CoV-2 Variants Circulating in Rajasthan in 2025 26.06.2026
Coevolving Mutations in Chronic SARS-CoV-2 Infections 25.06.2026
Bioelectrochemical Sensing Dynamics of SARS-CoV-2 Biomarkers. 25.06.2026
Skin as a Potential Entry Point for SARS-CoV-2 Virus. 15.06.2026
Nanobodies targeting SARS-CoV-2 variants. 12.06.2026
Mitochondrial OXPHOS restricts SARS-CoV-2 replication. 03.06.2026
Skin as a Potential Entry Point for SARS-CoV-2 Virus 01.06.2026
Wastewater-based surveillance for SARS-CoV-2 in Alberta 20.05.2026
Validation of a Mucosal IgA Assay for SARS-CoV-2. 20.05.2026
SARS-CoV-2 and reproductive system:a scientometric study. 14.05.2026
SARS-CoV-2:To transgress or Not? 07.05.2026
Epistasis and the changing fitness landscapes of SARS-CoV-2 13.03.2026
Immunological Evaluation of mRNA-LNP Vaccines Targeting Conserved S2 and NSP3 Domains of SARS-CoV-2. 01.01.1970
Protein-Protein Interactions Analyzed by the Fragment Molecular Orbital Method. 01.01.1970
Quellen: PubMed, Europe PMC & CrossRef
Grippe- und Corona-Impfung: Online-Fortbildung zum Saisonauftakt - Pharmazeutische Zeitung 18.08.2026
Post-COVID: Online-Seminare starten - Mittelhessen 18.08.2026
In Obwalden sind Covid-19-Härtefalldarlehen ab 2027 zinsfrei - Nau 18.08.2026
Long COVID: Fast 48% der Patienten erleben Virus-Reaktivierung - AD HOC NEWS 17.08.2026
Neue Spur zu schweren Infektionen: Coronavirus reaktiviert schlafende Viren im Körper - T-Online 17.08.2026
Corona-Impfung ab 75: STIKO ändert Empfehlung für Alter und Impfzeitpunkt - aponet.de 17.08.2026
Nachtschichtarbeit erhöht Long-Covid-Risiko dramatisch - Südtirol News 17.08.2026
Verdachtsfälle nach Covid-Impfungen - ZDFheute 17.08.2026
Impfschaden: Kampf um Anerkennung - ZDFheute 17.08.2026
Meinung: Long Covid und ME/CFS dürfen nicht unsichtbar bleiben - Badische Neueste Nachrichten 15.08.2026
Long Covid: UKE in Hamburg soll in neuer Ambulanz auch Patienten mit ME/CFS behandeln - Hamburger Abendblatt 15.08.2026
Studie: Nachtarbeit erhöht Risiko für Long Covid - science.ORF.at 12.08.2026
Was steckt hinter der Empörung über Fauci und Fehlgeburten? - rollingstone.de 12.08.2026
Fauci unter Druck: Geleakte Covid-Nachrichten gießen Öl ins Feuer - Frankfurter Rundschau 11.08.2026
COVID-19 - Auswärtiges Amt 10.08.2026
Wenn jeder Schritt zu viel ist: Leben mit ME/CFS und Long Covid - SWR 10.08.2026
Post Covid, ME/CFS: 3 Gerichtliche Gutachter auf Schadensersatz verklagt (Erwerbsminderungsrente) - Anwalt.de 09.08.2026
Hamburg Journal - Long Covid und ME/CFS: Betroffene demonstrieren in Hamburg - hier anschauen - ARD Mediathek 08.08.2026
Liegenddemo am UKE: PAIS-Betroffene fordern bessere Versorgung und hoffen auf Unterstützung - NDR.de 08.08.2026
Autoantikörper im Fokus: Neue Studie untersucht Herz- und Gefäßschäden bei Post-COVID-ME/CFS - Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) 20.07.2026
Quelle: Google News
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.